BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34186155)

  • 1. New aspects in the regulation of human B cell functions by complement receptors CR1, CR2, CR3 and CR4.
    Erdei A; Kovács KG; Nagy-Baló Z; Lukácsi S; Mácsik-Valent B; Kurucz I; Bajtay Z
    Immunol Lett; 2021 Sep; 237():42-57. PubMed ID: 34186155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-gamma activation inhibits complement receptor function and phagocytosis of this bacterium.
    Schlesinger LS; Horwitz MA
    J Immunol; 1991 Sep; 147(6):1983-94. PubMed ID: 1679838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3.
    Myones BL; Dalzell JG; Hogg N; Ross GD
    J Clin Invest; 1988 Aug; 82(2):640-51. PubMed ID: 2969921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Immunology of Complement Receptors 3 and 4.
    Vorup-Jensen T; Jensen RK
    Front Immunol; 2018; 9():2716. PubMed ID: 30534123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.
    Weis JJ; Tedder TF; Fearon DT
    Proc Natl Acad Sci U S A; 1984 Feb; 81(3):881-5. PubMed ID: 6230668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferation of resting B cells is modulated by CR2 and CR1.
    Fingeroth JD; Heath ME; Ambrosino DM
    Immunol Lett; 1989 Jun; 21(4):291-301. PubMed ID: 2527816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of complement C3 receptors on human astrocytes.
    Gasque P; Chan P; Mauger C; Schouft MT; Singhrao S; Dierich MP; Morgan BP; Fontaine M
    J Immunol; 1996 Mar; 156(6):2247-55. PubMed ID: 8690915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in complement-mediated phagocytosis and podosome formation by human phagocytes.
    Lukácsi S; Nagy-Baló Z; Erdei A; Sándor N; Bajtay Z
    Immunol Lett; 2017 Sep; 189():64-72. PubMed ID: 28554712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).
    Ahearn JM; Fearon DT
    Adv Immunol; 1989; 46():183-219. PubMed ID: 2551147
    [No Abstract]   [Full Text] [Related]  

  • 10. gp140, a C3b-binding membrane component of lymphocytes, is the B cell C3dg/C3d receptor (CR2) and is distinct from the neutrophil C3dg receptor (CR4).
    Frade R; Myones BL; Barel M; Krikorian L; Charriaut C; Ross GD
    Eur J Immunol; 1985 Dec; 15(12):1192-7. PubMed ID: 3878789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3.
    Vik DP; Fearon DT
    J Immunol; 1985 Apr; 134(4):2571-9. PubMed ID: 3156185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) in promoting C3 fragment deposition and membrane attack complex formation on normal peripheral human B cells.
    Nielsen CH; Pedersen ML; Marquart HV; Prodinger WM; Leslie RG
    Eur J Immunol; 2002 May; 32(5):1359-67. PubMed ID: 11981823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation of CR1 (CD35), CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in membranoproliferative glomerulonephritis type I.
    Soma J; Saito T; Seino J; Sato H; Ootaka T; Yusa A; Abe K
    Clin Exp Immunol; 1995 May; 100(2):269-76. PubMed ID: 7743666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-operation between human CR1 (CD35) and CR2 (CD21) in internalization of their C3b and iC3b ligands by murine-transfected fibroblasts.
    Grattone ML; Villiers CL; Villiers MB; Drouet C; Marche PN
    Immunology; 1999 Sep; 98(1):152-7. PubMed ID: 10469246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
    Ross GD; Newman SL; Lambris JD; Devery-Pocius JE; Cain JA; Lachmann PJ
    J Exp Med; 1983 Aug; 158(2):334-52. PubMed ID: 6224880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated Human Memory B Lymphocytes Use CR4 (CD11c/CD18) for Adhesion, Migration, and Proliferation.
    Nagy-Baló Z; Kiss R; Menge A; Bödör C; Bajtay Z; Erdei A
    Front Immunol; 2020; 11():565458. PubMed ID: 33133077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of murine complement receptor type 2 and its immunological cross-reactivity with type 1 receptor.
    Kinoshita T; Thyphronitis G; Tsokos GC; Finkelman FD; Hong K; Sakai H; Inoue K
    Int Immunol; 1990; 2(7):651-9. PubMed ID: 1703784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human umbilical vein endothelial cells express complement receptor 1 (CD35) and complement receptor 4 (CD11c/CD18) in vitro.
    Langeggen H; Berge KE; Johnson E; Hetland G
    Inflammation; 2002 Jun; 26(3):103-10. PubMed ID: 12083416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression, molecular association, and functions of C3 complement receptors CR1 (CD35) and CR2 (CD21) on the human T cell line HPB-ALL.
    Delibrias CC; Fischer E; Bismuth G; Kazatchkine MD
    J Immunol; 1992 Aug; 149(3):768-74. PubMed ID: 1386093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage cytoskeleton association with CR3 and CR4 regulates receptor mobility and phagocytosis of iC3b-opsonized erythrocytes.
    Ross GD; Reed W; Dalzell JG; Becker SE; Hogg N
    J Leukoc Biol; 1992 Feb; 51(2):109-17. PubMed ID: 1358992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.